Literature DB >> 29192652

ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity.

Natasha Lewis1, Robert A Soslow1, Deborah F Delair1, Kay J Park1, Rajmohan Murali1, Travis J Hollmann1, Ben Davidson2,3, Francesca Micci4, Ioannis Panagopoulos4, Lien N Hoang5, Javier A Arias-Stella1, Esther Oliva6,7, Robert H Young6,7, Martee L Hensley8, Mario M Leitao9, Meera Hameed1, Ryma Benayed1, Marc Ladanyi1, Denise Frosina1, Achim A Jungbluth1, Cristina R Antonescu1, Sarah Chiang1.   

Abstract

High-grade endometrial stromal sarcoma likely encompasses underrecognized tumors harboring genetic abnormalities besides YWHAE-NUTM2 fusion. Triggered by three initial endometrial stromal sarcomas with ZC3H7B-BCOR fusion characterized by high-grade morphology and aggressive clinical behavior, we herein investigate the clinicopathologic features of this genetic subset by expanding the analysis to 17 such tumors. All of them occurred in adult women with a median age of 54 (range, 28-71) years. They were predominantly based in the endomyometrium and demonstrated tongue-like and/or pushing myometrial invasion. Most were uniformly cellular and displayed haphazard fascicles of spindle cells with mild to moderate nuclear atypia. Myxoid matrix was seen in 14 of 17 (82%) tumors, and collagen plaques were seen in 8 (47%). The mitotic index was ≥10 mitotic figures/10 high-power fields (HPFs) in 14 of 17 (82%) tumors with a median of 14.5 mitotic figures/10 HPFs. No foci of conventional or variant low-grade endometrial stromal sarcoma were seen. All tumors expressed CD10 with only limited or absent desmin, SMA and/or h-caldesmon staining. ER and PR expression in >5% of cells was seen in 4 of 12 (33%) tumors. Diffuse cyclin D1 and BCOR immunoreactivity was present in 7 of 8 (88%) and 7 of 14 (50%) tumors, respectively. Fluorescence in situ hybridization or targeted RNA sequencing confirmed ZC3H7B-BCOR fusion in all tumors, including four and two previously diagnosed as myxoid leiomyosarcoma and undifferentiated uterine sarcoma, respectively. Limited clinical data suggest that patients present at higher stage and have worse prognosis compared with published outcomes in low-grade endometrial stromal sarcoma. Tumors with ZC3H7B-BCOR fusion constitute a distinct group of endometrial stromal sarcomas with high-grade morphology that should be distinguished from other uterine mesenchymal neoplasms that may demonstrate myxoid morphology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29192652     DOI: 10.1038/modpathol.2017.162

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  45 in total

1.  Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.

Authors:  Vera Grossmann; Enrico Tiacci; Antony B Holmes; Alexander Kohlmann; Maria Paola Martelli; Wolfgang Kern; Ariele Spanhol-Rosseto; Hans-Ulrich Klein; Martin Dugas; Sonja Schindela; Vladimir Trifonov; Susanne Schnittger; Claudia Haferlach; Renato Bassan; Victoria A Wells; Orietta Spinelli; Joseph Chan; Roberta Rossi; Stefano Baldoni; Luca De Carolis; Katharina Goetze; Hubert Serve; Rudolf Peceny; Karl-Anton Kreuzer; Daniel Oruzio; Giorgina Specchia; Francesco Di Raimondo; Francesco Fabbiano; Marco Sborgia; Arcangelo Liso; Laurent Farinelli; Alessandro Rambaldi; Laura Pasqualucci; Raul Rabadan; Torsten Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2011-10-19       Impact factor: 22.113

2.  Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.

Authors:  Jennifer A Bennett; Valentina Nardi; Marjan Rouzbahman; Vicente Morales-Oyarvide; G Petur Nielsen; Esther Oliva
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

3.  The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.

Authors:  Cheng-Han Lee; Adrian Mariño-Enriquez; Wenbin Ou; Meijun Zhu; Rola H Ali; Sarah Chiang; Frédéric Amant; C Blake Gilks; Matt van de Rijn; Esther Oliva; Maria Debiec-Rychter; Paola Dal Cin; Jonathan A Fletcher; Marisa R Nucci
Journal:  Am J Surg Pathol       Date:  2012-05       Impact factor: 6.394

4.  High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.

Authors:  Andrew P Sciallis; Patrick P Bedroske; John K Schoolmeester; William R Sukov; Gary L Keeney; Jennelle C Hodge; Debra A Bell
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

5.  Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Authors:  R Coleman Lindsley; Brenton G Mar; Emanuele Mazzola; Peter V Grauman; Sarah Shareef; Steven L Allen; Arnaud Pigneux; Meir Wetzler; Robert K Stuart; Harry P Erba; Lloyd E Damon; Bayard L Powell; Neal Lindeman; David P Steensma; Martha Wadleigh; Daniel J DeAngelo; Donna Neuberg; Richard M Stone; Benjamin L Ebert
Journal:  Blood       Date:  2014-12-30       Impact factor: 22.113

6.  Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.

Authors:  Jack F Shern; Li Chen; Juliann Chmielecki; Jun S Wei; Rajesh Patidar; Mara Rosenberg; Lauren Ambrogio; Daniel Auclair; Jianjun Wang; Young K Song; Catherine Tolman; Laura Hurd; Hongling Liao; Shile Zhang; Dominik Bogen; Andrew S Brohl; Sivasish Sindiri; Daniel Catchpoole; Thomas Badgett; Gad Getz; Jaume Mora; James R Anderson; Stephen X Skapek; Frederic G Barr; Matthew Meyerson; Douglas S Hawkins; Javed Khan
Journal:  Cancer Discov       Date:  2014-01-23       Impact factor: 39.397

7.  BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

Authors:  Frederik Damm; Virginie Chesnais; Yasunobu Nagata; Kenichi Yoshida; Laurianne Scourzic; Yusuke Okuno; Raphael Itzykson; Masashi Sanada; Yuichi Shiraishi; Véronique Gelsi-Boyer; Aline Renneville; Satoru Miyano; Hiraku Mori; Lee-Yung Shih; Sophie Park; François Dreyfus; Agnes Guerci-Bresler; Eric Solary; Christian Rose; Stéphane Cheze; Thomas Prébet; Norbert Vey; Marion Legentil; Yannis Duffourd; Stéphane de Botton; Claude Preudhomme; Daniel Birnbaum; Olivier A Bernard; Seishi Ogawa; Michaela Fontenay; Olivier Kosmider
Journal:  Blood       Date:  2013-09-18       Impact factor: 22.113

8.  BCOR internal tandem duplication and YWHAE-NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney.

Authors:  Jenny Karlsson; Anders Valind; David Gisselsson
Journal:  Genes Chromosomes Cancer       Date:  2015-10-23       Impact factor: 5.006

Review 9.  The management of patients with uterine sarcoma: a debated clinical challenge.

Authors:  Angiolo Gadducci; Stefania Cosio; Antonella Romanini; Andrea Riccardo Genazzani
Journal:  Crit Rev Oncol Hematol       Date:  2007-08-13       Impact factor: 6.312

10.  Myxoid leiomyosarcoma of the uterus. A report of six cases.

Authors:  M E King; G R Dickersin; R E Scully
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

View more
  29 in total

1.  DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics.

Authors:  Felix K F Kommoss; Damian Stichel; Daniel Schrimpf; Mark Kriegsmann; Basile Tessier-Cloutier; Aline Talhouk; Jessica N McAlpine; Kenneth T E Chang; Dominik Sturm; Stefan M Pfister; Laura Romero-Pérez; Thomas Kirchner; Thomas G P Grünewald; Rolf Buslei; Hans-Peter Sinn; Gunhild Mechtersheimer; Peter Schirmacher; Dietmar Schmidt; Hans-Anton Lehr; Felix Sahm; David G Huntsman; C Blake Gilks; Friedrich Kommoss; Andreas von Deimling; Christian Koelsche
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-25       Impact factor: 4.553

2.  ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change.

Authors:  Ondrej Ondič; Barbora Bednářová; Nikola Ptáková; Veronika Hájková; Petr Šteiner; Henrieta Šidlová; Jiří Presl; Jiří Bouda; Reza Alaghehbandan; Michal Michal
Journal:  Virchows Arch       Date:  2020-01-14       Impact factor: 4.064

Review 3.  [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].

Authors:  S F Lax
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

Review 4.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

5.  PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.

Authors:  Sarah Chiang; Wesley Samore; Lei Zhang; Yun-Shao Sung; Gulisa Turashvili; Rajmohan Murali; Robert A Soslow; Martee L Hensley; David Swanson; Brendan C Dickson; Colin J R Stewart; Esther Oliva; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

6.  Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.

Authors:  Paolo Cotzia; Ryma Benayed; Kerry Mullaney; Esther Oliva; Ana Felix; Joana Ferreira; Robert A Soslow; Cristina R Antonescu; Marc Ladanyi; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2019-05       Impact factor: 6.394

Review 7.  LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.

Authors:  Chunhui Li; Chunhong Wang
Journal:  J Zhejiang Univ Sci B       Date:  2021-08-15       Impact factor: 3.066

8.  Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.

Authors:  Jennifer A Bennett; Zehra Ordulu; Robert H Young; Andre Pinto; Koen Van de Vijver; Eike Burandt; Pankhuri Wanjari; Rajeev Shah; Leanne de Kock; William D Foulkes; W Glenn McCluggage; Lauren L Ritterhouse; Esther Oliva
Journal:  Mod Pathol       Date:  2021-05-20       Impact factor: 7.842

9.  Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma.

Authors:  Amir Momeni-Boroujeni; Nissreen Mohammad; Robert Wolber; Stephen Yip; Martin Köbel; Brendan C Dickson; Martee L Hensley; Mario M Leitao; Cristina R Antonescu; Ryma Benayed; Marc Ladanyi; Cheng-Han Lee; Sarah Chiang
Journal:  Mod Pathol       Date:  2020-10-19       Impact factor: 7.842

10.  Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation.

Authors:  Pier Selenica; Niamh Conlon; Carlene Gonzalez; Denise Frosina; Achim A Jungbluth; Regina G H Beets-Tan; Mamta K Rao; Yanming Zhang; Ryma Benayed; Marc Ladanyi; David B Solit; Sarah Chiang; David M Hyman; Martee L Hensley; Robert A Soslow; Britta Weigelt; Rajmohan Murali
Journal:  Am J Surg Pathol       Date:  2021-01       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.